Concussions Market Research Report - Global Forecast till 2030

Concussions Market: Information by Treatment (Diagnosis and Treatment) by End User (Hospitals and Clinics, Diagnostic Centers and Payers) & Region - Global Forecast till 2030

ID: MRFR/Pharma/4269-CR | July 2019 | Region: Global | 145 pages         

Concussions Market

The Concussions Market is anticipated to grow a CAGR of 3.33% during the forecast period. The concussion market is expected to reach a revenue of USD 1337.17 million by 2030.


By Treatment Diagnosis and Treatment
End User Hospitals and Clinics Diagnostic Centers and Payers

Key Players

  • Teva Pharmaceutical Industries Ltd
  • Integra LifeSciences Corporation
  • Medtronic PLC
  • Sun Pharmaceutical Industries Ltd
  • Lupin
  • Zydus Cadila
  • Pfizer
  • Inc.
  • Mylan NV
  • Novartis AG
  • Sanofi SA


  • Increasing incidence of mild traumatic brain injuries
  • The rising cases of road accidents.
Speak to Analyst Request a Free Sample

Concussions Market Overview

Based on the concussions statistics, the Concussions Market is anticipated to grow a CAGR of 3.33% during the forecast period. The concussion market is expected to reach a revenue of USD 1337.17 million by 2030.

Concussion disrupts the normal functionality of the brain for a short period of time. It is generally a mild traumatic injury in the brain. This situation usually caused by any jolt or blow on the head. A hit to the body producing a reflex force to the head causes such situation which is very common in sports, falls and car crashes.

Rising incidents of brain injuries and increasing development in products, with growing geriatric population is propelling the market growth. However, the lack of trained professional, and regulatory framework are keeping the market in various challenges. The BrainScope company, Inc recently launched Ahead 300 to assess all the head injuries along with concussion. These technological advancements are expected to boost the concussion market growth during the forecast period.

The types of concussion market are ranked by the doctors as levels of concussions; Grade 1 (mild), Grade 2 (moderate), Grade 3 (severe). There are many common physical, mental and emotional concussions symptoms connected to the injury such as feeling dazed or confused, slurred speech, clumsiness, headache, nausea, dizziness, sensitivity to light, blurred vision, sluggishness, sensitivity to noise, irritability and behaviour changes, memory loss, difficulty concentrating, loss of consciousness, fatigue, forgetfulness, sleeping problems, depression, slow responses, problems with smell and taste.

There is no prominent medication for concussions is available. However, doctors use some basic medication on the first hour of injury as bleeding inside the brain can become risky and fatal.

Covid-19 impact of Concussions Market

The covid-19 pandemic has negatively impacted many industries across the globe. Governments had to take decisions of lockdowns for uncertain period. The concussion industry is no different. Many industries was forced to restrict their operations due to the lockdown. These are the factors expected to impact the concussion market negatively.

Concussion Market Dynamics

Although the concussion is referred as a mild head injury, but effects can be serious. The usual causes of concussion are domestic violence, fall, sports injuries, road accident injury and gunshot wounds. In U.s, the leading causes of concussion are 52% from fall, 20% from road accident injuries, 17% from being hit or collided and 11% from assault. According to the CDC report, the amount of sports related injuries are 1.6 million to 3.8 million every year. Therefore, it means approx every 1 in 5 athletes suffer from head injury in US. CDC (National Centre for injury Prevention and Control) also states that approx vehicle related injuries were 3,432 in 2018.


The rising cases of road accidents, assaults, hit or jab, domestic violence, fall and sports injuries in the brain are likely to provide the momentum to the concussion market growth during the forecast period. Moreover, the rising amount of research and developments made by the scientists and putting efforts to improve the physician understandings on the concussion i.e. the mild traumatic brain injury. The Track TBI has conducted a research steady for developing the new classifications of the traumatic brain injuries which is expectedly improve the diagnosis and prognosis for the related patient.


The technical development and advancement in concussion evaluating machinery are likely to create a huge opportunity in the concussion market. The advanced technology included rapid point-of-care in concussion test in as less as two minutes of time. It also improved with the eye tracking based concussion tests.


The lack of trained professionals in the field of concussion can become a restraining factor for handling the concussions symptoms and treatment.


The concussion market lacking the strict regulatory framework is expected to be a challenging factor the for the treatment for mild concussions.

Global Concussions Market Revenue, by, 2017 & 2023 (USD Million)  Concussions Market

Sources: MRFR Analysis

Segmentation overview

Based on the Concussions Market, it is segmented into-


  • Diagnosis and Treatment

  • End User

  • Region


By Diagnosis and Treatment


Based on diagnosis and treatment, the concussion market is further classified into-

  • Diagnosis

  • Treatment



By End User


Based on end-users, the concussion market is further segmented into-

  • Hospitals and Clinics

  • Diagnostic Centers

  • Payers


By Region


Based on region, the concussion market is further classified into-

  • Americas

    • North America

      • US

      • Canada

    • Latin America

  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe

    • Eastern Europe

  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific

  • Middle East & Africa

    • Middle East

    • Africa

 Asia-Pacific Concussions Market Share, 2017(%)    Concussions Market          

Sources: MRFR Analysis

Regional analysis

The regional concussion market is divided into Americas, Europe, APAC and the MEA.

The America is further classified into North America and Latin America. The North America is expected  witness the highest and significant market growth during the forecast period. This region is prone to more accidents which is driving the market growth and the rising awareness spreading by several government organisations along with the private firms are providing the impetus to the market growth of the region.

The European market is likely to be the second largest Concussions Market. The growing numbers of cases causing concussions are driving the growth of the market.

APAC, among all the regional markets of Concussions Market, happens to be the fastest growing region. Additionally, the rise in the improvement of healthcare infrastructure has helped the high level research activities in the region. Moreover, the improvement of research and development centres in the region is likely to boost the growth of the market. Also, the ample amount of brain injuries are propelling the growth of the market. Based on countries, the dominating regions of APAC are Japan, China and India. In 2017, Japan had a market share of 19.3% of the entire regional concussion market.

Recent developments

October 2016-  Teva Pharmaceutical industries Ltd obtained Anda, Inc., the U.S based leading distributor of pharmaceuticals.

November 2018- Sun Pharma obtained Pola Pharma that is into manufacturing, R&D, sales and distribution of branded and generic products in Japan.

July 2018-  Lupin recieved the Medicines and Healthcare Products Regulatory Agency (MHRA) from UK approved for its Goa facility.

Major key players

  • Teva Pharmaceutical Industries Ltd

  • Integra LifeSciences Corporation

  • Medtronic PLC

  • Sun Pharmaceutical Industries Ltd

  • Lupin

  • Zydus Cadila

  • Pfizer, Inc.

  • Mylan NV

  • Novartis AG

  • Sanofi SA

Report Overview

The report comprises of        

  • Market overview

  • Covid-19 impact

  • Market dynamics

  • Drivers

  • Challenges

  • Restrains

  • Opportunities

  • Technological analysis

  • Segmentation overview

  • Regional analysis

  • Competitive landscape

  • Recent developments

  • Major key players

Report Scope:
Report Attribute/Metric Details
  Market Size   USD 1337.17 Million
  CAGR   3.33% (2020-2030)
  Base Year   2019
  Forecast Period   2020-2030
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Treatment and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Teva Pharmaceutical Industries Ltd, Integra LifeSciences Corporation, Medtronic PLC, Sun Pharmaceutical Industries Ltd, Lupin, Zydus Cadila, Pfizer, Inc., Mylan NV, Novartis AG, Sanofi SA
  Key Market Opportunities   The increase in the setups of research and development centers boosts the growth
  Key Market Drivers   Increasing incidence of mild traumatic brain injuries, ongoing product development, and approval growing geriatric population

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The global concussions market is predicted to touch USD 1337.17 million by 2030.

The concussions market is predicted to grow at a 3.33% CAGR between 2020-2030.

The Americas is projected to lead the concussions market during the forecast period.

Ongoing product development, increasing prevalence of mild traumatic brain injuries, and improved healthcare infrastructure are adding to the market growth.

Lack of trained professionals and strict regulatory framework may limit market growth.